≥99% HPLC Verified Mass Spec Confirmed Lyophilized RUO

TH9507 ” Compare to Tesamorelin”

$94.95

TH9507 is the research designation for tesamorelin, a synthetic 44-amino-acid version of growth-hormone-releasing hormone (GHRH) with a trans-hexenoyl group added to the start of the chain. Published work reported that this modification protects it from DPP-IV, an enzyme that otherwise cleaves GHRH.

Size

Account required · Research professionals only

Purity ≥99% RP-HPLC

Identity Confirmed RP-HPLC

Analysis Lot Tested 3rd-Party Lab

DOWNLOAD COA

Research Application

Typical laboratory uses: GHRH receptor selectivity assays, DPP-IV enzyme-stability tests, and fat-cell (adipocyte) metabolism studies. For in-vitro laboratory research only. Not for human or animal use.

Research Use Only. This compound is supplied strictly for in-vitro laboratory research by qualified professionals. Not for human or veterinary administration. By purchasing you confirm compliance with all applicable regulations.

Compound Specifications

Compound	TH9507 " Compare to Tesamorelin"
Sequence	trans-hexenoyl-GRF(1-44)-NH2 (44 AA in Tesamorelin; site printed 29-AA sequence truncated!)
Molecular Formula	C221H366N72O67S (Formula for 44-AA)
Molecular Weight	5135.9 g/mol (MW for 44-AA)
CAS Number	218949-48-5
Purity Specification	≥99% by RP-HPLC
Identity Testing	Confirmed by Mass Spectrometry
Physical Form	White lyophilized powder

Primary Scientific Literature & Preclinical Citations

Peer-Reviewed

The following peer-reviewed scientific publications report preclinical investigations into the biochemical mechanisms and receptor pharmacology of this compound. RHPeptides supplies this material strictly for in-vitro laboratory research.

Ferdinandi ES et al. (2007) · Basic Clin Pharmacol Toxicol

PMID: 17214611 ↗ DOI ↗

Model: In-vitro rat and dog hepatocytes / in-vivo animal PK

Finding: N-terminal hexenoyl modification prevents DPP-IV enzymatic cleavage